Finder Award
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy IO Biotech stock
Learn how to easily invest in IO Biotech stock.
IO Biotech is a biotechnology business based in the US. IO Biotech shares (IOBT) are listed on the NASDAQ and all prices are listed in US Dollars. IO Biotech employs 57 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy IO Biotech stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – IOBT. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Finder Award
Finder Award
eToro
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
tastytrade
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
IO Biotech stock price (NASDAQ: IOBT)
Use our graph to track the performance of IOBT stocks over time.IO Biotech shares at a glance
Information last updated 2023-05-20.
| Latest market close | $2.03 |
|---|---|
| 52-week range | $1.72 - $5.77 |
| 50-day moving average | $1.98 |
| 200-day moving average | $2.62 |
| Wall St. target price | $11.75 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-2.52 |
Buy IO Biotech stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 5 of 5
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy IO Biotech stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
IO Biotech price performance over time
Historical closes compared with the close of $2.025 from 2023-05-26
| 1 week (2023-05-19) | 1.25% |
|---|---|
| 1 month (2023-04-28) | 6.02% |
| 3 months (2023-02-28) | -20.28% |
| 6 months (2022-11-28) | -34.68% |
| 1 year (2022-05-27) | -55.49% |
|---|---|
| 2 years (2021-05-24) | N/A |
| 3 years (2020-05-24) | N/A |
| 5 years (2018-05-24) | N/A |
IO Biotech financials
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -23.87% |
| Return on equity TTM | -40.74% |
| Profit margin | 0% |
| Book value | $4.82 |
| Market capitalisation | $57.6 million |
TTM: trailing 12 months
IO Biotech share dividends
We're not expecting IO Biotech to pay a dividend over the next 12 months.
You may also wish to consider:
- AstraZeneca PLC ADR (AZN.US) (1.95% forward annual dividend yield)
- AbbVie (ABBV.US) (4.27% forward annual dividend yield)
- BioNTech (BNTX.US) (1.33% forward annual dividend yield)
IO Biotech overview
IO Biotech, Inc. , a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 1 clinical trial to treat lung, head and neck, bladder, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers. The company was incorporated in 2014 and is based in Copenhagen, Denmark. .
IO Biotech in the news
IO Biotech Announces 2023 First-Quarter Results
Frequently asked questions
What percentage of IO Biotech is owned by insiders or institutions?Currently 11.136% of IO Biotech shares are held by insiders and 78.955% by institutions. How many people work for IO Biotech?
Latest data suggests 57 work at IO Biotech. When does the fiscal year end for IO Biotech?
IO Biotech's fiscal year ends in December. Where is IO Biotech based?
IO Biotech's address is: Ole Maaløes Vej 3, Copenhagen, Denmark, 2200 What is IO Biotech's ISIN number?
IO Biotech's international securities identification number is: US4497781090
More guides on Finder
-
JP Morgan Personal Advisors review 2023
Access remote advice, planning and portfolio management from this established financial services company.
-
How to buy Energy Transfer Equity stock
Steps to owning and managing ET, with 24-hour and historical pricing before you buy.
-
How to buy Uranium Energy stock
Steps to owning and managing UEC, with 24-hour and historical pricing before you buy.
-
How to buy Gold Royalty stock
Steps to owning and managing GROY, with 24-hour and historical pricing before you buy.
-
Best apps and platforms for ETF investing
The best trading apps come with low fees and are easy to use.
-
What happens if a brokerage firm fails?
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
-
Best online brokers & platforms to buy gold stocks in May 2023
Learn about buying physical gold, plus stocks and ETFs, to learn how you can add gold exposure to your portfolio.
-
Silicon Valley Bank collapse: Which ETFs and stocks are impacted?
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
-
How to buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
-
SVB collapses: What does it mean for your portfolio?
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
Ask an Expert